Erste Asset Management GmbH Purchases Shares of 9,650 Cabot Corporation $CBT

Erste Asset Management GmbH purchased a new stake in shares of Cabot Corporation (NYSE:CBT) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 9,650 shares of the specialty chemicals company’s stock, valued at approximately $872,000.

Other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new stake in Cabot in the fourth quarter valued at $49,662,000. AQR Capital Management LLC raised its position in Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after purchasing an additional 478,702 shares during the last quarter. UBS Group AG lifted its holdings in Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after buying an additional 386,514 shares during the period. Pacer Advisors Inc. lifted its holdings in Cabot by 3,165.7% during the 4th quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock worth $15,195,000 after buying an additional 222,232 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Cabot in the 4th quarter valued at about $8,785,000. Institutional investors own 93.18% of the company’s stock.

Insider Activity at Cabot

In other news, CEO Sean D. Keohane sold 91,923 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the completion of the sale, the chief executive officer owned 404,134 shares in the company, valued at $34,921,218.94. The trade was a 18.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 3.08% of the stock is currently owned by corporate insiders.

Cabot Price Performance

Shares of NYSE CBT opened at $86.28 on Friday. The firm has a market capitalization of $4.45 billion, a P/E ratio of 24.30, a P/E/G ratio of 11.26 and a beta of 0.84. The firm’s 50-day moving average price is $87.98 and its 200-day moving average price is $80.34. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $94.53.

Cabot (NYSE:CBT) last issued its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating the consensus estimate of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million during the quarter, compared to the consensus estimate of $943.16 million. During the same period last year, the business posted $1.90 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities research analysts anticipate that Cabot Corporation will post 6.33 earnings per share for the current fiscal year.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is 53.24%.

Wall Street Analysts Forecast Growth

CBT has been the subject of a number of analyst reports. Mizuho raised their price objective on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. JPMorgan Chase & Co. upped their target price on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. UBS Group lowered their price target on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a report on Wednesday, August 5th. Finally, Truist Financial set a $100.00 price target on shares of Cabot in a research report on Wednesday, August 5th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Cabot has a consensus rating of “Hold” and an average price target of $89.00.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.